Moderna stock crash proves markets trade on yield not hope
Moderna stock dropped after leaked trial data missed market expectations, showing that speculative capital demands precise yield over corporate secrecy.
By Bram de Vries ·
Moderna stock dropped after leaked trial data missed market expectations, showing that speculative capital demands precise yield over corporate secrecy.
By Bram de Vries ·
The market’s reaction to Moderna and Merck's personalized mRNA vaccine for melanoma—a spectacular 177% surge in Moderna’s stock, according to CNBC—is pure adrenaline.
By Dana Whitfield ·
The sheer velocity of the stock market is always the most exhausting part of any major announcement.
By Aoife Gallagher ·
I’ve spent my life scoring things in payroll. I track whether a promise lands on a spreadsheet: who gets hired, at what wage, and if the work remains there five years from now.
By Ray Dombrowski ·